Загрузка...
Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2)
Only one-third of elderly (>60 years) AML and MDS-RAEB2 patients may receive intensive chemotherapy treatment alternatives that are limited in this patient group due to the potential of severe toxicity. Previous studies have shown that azacitidine and low dose cytarabine treatments may be a benef...
Сохранить в:
| Опубликовано в: : | Indian J Hematol Blood Transfus |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer India
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4733667/ https://ncbi.nlm.nih.gov/pubmed/26855506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-015-0509-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|